Tilray Brands, Inc. (TLRY) Ascends While Market Falls: Some Facts to Note

In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $7.99, marking a +2.04% move from the previous day. This move outpaced the S&P 500's daily loss of 0.54%. Meanwhile, the Dow experienced a rise of 0.03%, and the technology-dominated Nasdaq saw a decrease of 1.18%.

The company's shares have seen a decrease of 0.25% over the last month, surpassing the Medical sector's loss of 0.62% and falling behind the S&P 500's gain of 0.58%.

The upcoming earnings release of Tilray Brands, Inc. will be of great interest to investors. In that report, analysts expect Tilray Brands, Inc. to post earnings of -$0.14 per share. This would mark year-over-year growth of 86%. Simultaneously, our latest consensus estimate expects the revenue to be $205.93 million, showing a 10.85% escalation compared to the year-ago quarter.

For the full year, the Zacks Consensus Estimates project earnings of -$0.56 per share and a revenue of $871.99 million, demonstrating changes of -660% and +6.17%, respectively, from the preceding year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Tilray Brands, Inc. Recent revisions tend to reflect the latest near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Tilray Brands, Inc. presently features a Zacks Rank of #3 (Hold).

The Medical - Products industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 145, placing it within the bottom 41% of over 250 industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

Just Released: Zacks Top 10 Stocks for 2026

Hurry – you can still get in early on our 10 top tickers for 2026. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful.

From inception in 2012 through November, 2025, the Zacks Top 10 Stocks gained +2,530.8%, more than QUADRUPLING the S&P 500’s +570.3%.

Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2026. You can still be among the first to see these just-released stocks with enormous potential.

See New Top 10 Stocks >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Tilray Brands, Inc. (TLRY): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research